跳至主導覽
跳至搜尋
跳過主要內容
排序方式
Keyphrases
Akt Activation
50%
AKT Pathway
100%
Antineoplastic Agents
12%
Antiproliferative Activity
12%
Benzenesulfonamide
12%
Celecoxib
100%
Celecoxib Analogs
12%
Cyclooxygenase-2
100%
Dephosphorylation
12%
Differential Reduction
12%
G1 Arrest
12%
High Concentration
12%
IC50
12%
IC50 Value
12%
In Vivo Efficacy
12%
Independent Pathway
12%
Induced Apoptosis
12%
Inhibitory Activity
12%
Marginal Impact
12%
PC-3
12%
PC-3 Cells
12%
PDK1
100%
Phospho-Akt
12%
Prostate Cancer Cells
100%
Protein Phosphatase 2A (PP2A)
12%
Pyrazol
12%
Relative Contribution
12%
Relative Potency
12%
Trifluoromethyl
12%
Tumor Samples
12%
Xenograft Tumor
12%
Xenograft Tumor Growth
12%
Biochemistry, Genetics and Molecular Biology
Akt Signaling
100%
Antiproliferative Activity
11%
Cancer Cell
100%
Celecoxib
100%
Cyclooxygenase
100%
Dephosphorylation
11%
G1/S Transition
11%
IC50
22%
Independent Pathway
11%
Phosphoinositide-Dependent Kinase-1
100%
Phosphoprotein Phosphatase
11%
Programmed Cell Death
11%
Protein Kinase B
66%
Tumor Progression
11%
Pharmacology, Toxicology and Pharmaceutical Science
Benzenesulfonamide
11%
Celecoxib
100%
Cyclooxygenase 2
100%
IC50
22%
Neoplasm
22%
Phosphoinositide Dependent Protein Kinase 1
100%
Phosphoprotein Phosphatase 2A
11%
Prostate Cancer
100%
Protein Kinase B
100%
Tumor Growth
11%
Neuroscience
Akt Signaling
100%
Celecoxib
100%
Cyclooxygenase 2
100%
Dephosphorylation
11%
G1 Phase Cell Cycle Checkpoint
11%
In Vitro
22%
Phosphoinositide-Dependent Kinase-1
100%
Phosphoprotein Phosphatase 2A
11%
Programmed Cell Death
11%
Protein Kinase B
66%
Immunology and Microbiology
Akt Signaling
100%
Antiproliferative Activity
16%
Cancer Cell
100%
Cyclooxygenase
100%
Dephosphorylation
16%
G1 Phase Cell Cycle Checkpoint
16%
IC50
33%
Programmed Cell Death
16%
Xenograft
33%